ABMT (Advanced BioMedical Technologies) Gross Profit: $0.08 Mil (TTM As of Jul. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced BioMedical Technologies Gross Profit?

Advanced BioMedical Technologies ABMT Gross Profit is $0.08 Mil as of Jul. 2021.

Advanced BioMedical Technologies's gross profit for the three months ended in Jul. 2021 was $0.00 Mil. Advanced BioMedical Technologies's gross profit for the trailing twelve months (TTM) ended in Jul. 2021 was $0.08 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Advanced BioMedical Technologies's gross profit for the three months ended in Jul. 2021 was $0.00 Mil. Advanced BioMedical Technologies's Revenue for the three months ended in Jul. 2021 was $0.00 Mil. Therefore, Advanced BioMedical Technologies's Gross Margin % for the quarter that ended in Jul. 2021 was N/A%.

Advanced BioMedical Technologies had a gross margin of N/A% for the quarter that ended in Jul. 2021 => No sustainable competitive advantage


Advanced BioMedical Technologies  (OTCPK:ABMT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Advanced BioMedical Technologies had a gross margin of N/A% for the quarter that ended in Jul. 2021 => No sustainable competitive advantage


Advanced BioMedical Technologies Gross Profit Related Terms


Advanced BioMedical Technologies Gross Profit Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Gross Profit Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.07

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.04 0.04 0.00 0.00

ABMT vs VYCO, ADMT, THMO: Gross Profit Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced BioMedical Technologies Gross Profit vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Gross Profit falls into.



Advanced BioMedical Technologies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Advanced BioMedical Technologies's Gross Profit for the fiscal year that ended in Oct. 2020 is calculated as

Gross Profit (A: Oct. 2020 )=Revenue - Cost of Goods Sold
=0.124 - 0.052
=0.07

Advanced BioMedical Technologies's Gross Profit for the quarter that ended in Jul. 2021 is calculated as

Gross Profit (Q: Jul. 2021 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Advanced BioMedical Technologies's Gross Margin % for the quarter that ended in Jul. 2021 is calculated as

Gross Margin % (Q: Jul. 2021 )=Gross Profit (Q: Jul. 2021 ) / Revenue (Q: Jul. 2021 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $0.08 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Gross Profit of $0.08 Mil as of Jul. 2021. Gross Profit equals net sales less total cost of goods sold. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Gross Profit too high?
Advanced BioMedical Technologies' current Gross Profit is $0.08 Mil.
How does Advanced BioMedical Technologies' Gross Profit compare to VYCO and ADMT?
Advanced BioMedical Technologies' Gross Profit of $0.08 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Gross Profit is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Gross Profit of $0.08 Mil. The current Gross Profit is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Gross Profit is $0.08 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.